AbbVie
ABBV
#29
Rank
$332.79 B
Marketcap
$188.40
Share price
-0.78%
Change (1 day)
12.13%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - P/B ratio

P/B ratio as of July 2025 : 231

According to AbbVie's latest financial reports the company has a price-to-book ratio of 5.89713.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

AbbVie - P/B ratio (from 2012 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31N/A-100%
2024-12-3193.5255.34%
2023-12-3126.359.17%
2022-12-3116.56.61%
2021-12-3115.57.36%
2020-12-3114.4-190.14%
2019-12-31-16.0-0.73%
2018-12-31-16.1-153.29%
2017-12-3130.337.99%
2016-12-3122.0-9.2%
2015-12-3124.2-59.56%
2014-12-3159.8220.35%
2013-12-3118.716.28%
2012-12-3116.0
2011-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Pfizer
PFE
1.59-99.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
5.52-97.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
45.3-80.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
25.7-88.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
7.31-96.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
1.15-99.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
4.39-98.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
5.41-97.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
5.27-97.72%๐Ÿ‡บ๐Ÿ‡ธ USA